๐ ๐ ๐ฎ๐ฐ๐ต๐ถ๐ป๐ฒ ๐๐ฒ๐ฎ๐ฟ๐ป๐ถ๐ป๐ด ๐ก๐ผ๐๐ฒ๐ (๐๐ฎ๐ป๐ฑ๐๐ฟ๐ถ๐๐๐ฒ๐ป ๐ฃ๐๐)
Master the core of ๐ ๐ฎ๐ฐ๐ต๐ถ๐ป๐ฒ ๐๐ฒ๐ฎ๐ฟ๐ป๐ถ๐ป๐ด โalgorithms, models, training, evaluation & real-world examples. Perfect for interviews & AI enthusiasts! ๐ค๐
๐FREE for the first 500 people!
1. Like & Repost
2. Comment โMLโ
3. Follow (so I can DM you)
๐ก The future is machine learning, start learning today!
Strongest evidence so far: pulmonary embolism has an independent and long-term effect on quality of life. On the Eur J of Preventive Cardiology: https://t.co/hfiQZRnFKVโฆ
@lukashobohm@UnimedizinMainz@escardio@thrombosisday#PE
@DrDadSays@MushtaqBilalPhD It first states that trisomy 18 occurs in one-third of choroid plexus cysts, but immediately after states that it occurs in 1% of fetuses with choroid plexus cysts. There is a considerable difference between 33% and 1%.
Call for standardized follow-up after acute #PE. Serious underdiagnosis of #CTEPH in real-world setting demonstrated by our research group at the #ESCCongress. Presenting now by Dr. Karsten Keller at ScienceBox7 in #Amsterdam@ZI_Atlas @itfarmakis @Luca_Valery@StavrosKonstan7
In a new study from our group published in Anaerobe, official journal of @AnaerobeSociety, we showed that common laboratory parameters correlate with the clinical presentation of Lemierre syndrome, but have poor prognostic power:
https://t.co/O2GW8YBkxo
Performance Score is a valuable indicator for predicting #VTE-related outcomes and may inform decision-making regarding anticoagulation during follow-up in patients with cancer-associated PE. https://t.co/sjKy374aZt
#JACCCardioOnc#CardioOnc#cvVTE#cvCoag#ECOG#CardioTwitter
DON'T MISS IT: The latest #RPTHResearchRecap is live. Here, @DellucAurelien talks with @Luca_Valery about his latest paper in #RPTH which examines the reporting of #PE-related deaths in the @WHO mortality database...surprising results. Watch/listen here: https://t.co/CdiqBCdC2R
Researchers investigated rates of pulmonary embolism-related mortality in over 2.6 MILLION people across 123 countries in the @WHO mortality database. Read here to get a grasp on global #PE reporting: https://t.co/8OtGWQXysS
@stebarco @fniainle
Researchers investigated rates of pulmonary embolism-related mortality in over 2.6 MILLION people across 123 countries in the @WHO mortality database. Read here to get a grasp on global #PE reporting: https://t.co/8OtGWQXysS
@stebarco @fniainle
@journal_CHEST @stebarco Thank you - the largest analysis of disease-specific quality of life with PEmb-QoL in pulmonary embolism to date may contribute to the advancing field of long-term quality of life and functional status in VTE @Erik_Klok_MD @stebarco @UnimedizinM
In cohort of survivors of acute PE, QoL improved between 3-12 months, w/ disease-specific QoL lower in women & those w/ higher BMI or preexisting cardiopulmonary disease, & declined over time in older pts & those w/ history of VTE: https://t.co/kB07EzSEyP
@Luca_Valery @stebarco
The #BATTLE registry (Bacteria-Associated Thrombosis Thrombophlebitis and LEmierre syndrome) is designed to support development of guidelines https://t.co/PUd8zT1S2l
First evidence that the *dynamics* of D-Dimer and CRP (rather than just their absolute value) may have prognostic value in COVID-19. https://t.co/SdvZL2sZqT
@stebarco @TH_Journal#COVID19#COVIDใผ19
For me, this is an important paper - we lack adequate epidemiological data on VTE mortality & this beautifully defines rates in North America with signposts to area that need attention - cancer & ethnicity as risk factors
Thanks to @stebarco for leading
It's #WorldThrombosisDay โ read NEW Research from Stefano Barco & colleagues on age-sex specific #pulmonary#embolism-related mortality in the USA and Canada, 2000โ18
https://t.co/8DBpIoC0uZ
@S_B_Galvin @ClausWilke I became a fan after nearly losing my mental sanity by restructuring the same dataset in 25 new subdatasets for 25 figures instead of piping the same dataset into some modification and then into ggplot. Recently started with forward assignment as well.